Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The Nithsdale schizophrenia survey: I. Psychiatric and social handicaps.

McCreadie RG.

Br J Psychiatry. 1982 Jun;140:582-6.

PMID:
7104546
2.

The Nithsdale Schizophrenia survey: II. Abnormal movements.

McCreadie RG, Barron ET, Winslow GS.

Br J Psychiatry. 1982 Jun;140:587-90.

PMID:
6125227
3.

The Nithsdale schizophrenia survey: III. Handedness and tardive dyskinesia.

McCreadie RG, Crorie J, Barron ET, Winslow GS.

Br J Psychiatry. 1982 Jun;140:591-4.

PMID:
7104547
4.

Nithsdale schizophrenia surveys. 17. Fifteen year review.

Kelly C, McCreadie RG, MacEwan T, Carey S.

Br J Psychiatry. 1998 Jun;172:513-7.

PMID:
9828992
5.

Nithsdale, Nunhead and Norwood: similarities and differences in prevalence of schizophrenia and utilisation of services in rural and urban areas.

McCreadie RG, Leese M, Tilak-Singh D, Loftus L, MacEwan T, Thornicroft G.

Br J Psychiatry. 1997 Jan;170:31-6.

PMID:
9068772
6.

[Acute schizophrenia concept and definition: investigation of a French psychiatrist population].

Baylé FJ, Misdrahi D, Llorca PM, Lançon C, Olivier V, Quintin P, Azorin JM.

Encephale. 2005 Jan-Feb;31(1 Pt 1):10-7. French.

PMID:
15971635
7.
8.

The Nithsdale schizophrenia survey. IV. Social adjustment by self-report.

McCreadie RG, Barron ET.

Br J Psychiatry. 1984 May;144:547-50.

PMID:
6733383
9.

[Schizophrenia and violence, incidence and risk factors: a Tunisian sample].

Ellouze F, Ayedi S, Masmoudi S, Bakri L, Chérif W, Zramdini R, Largueche M, Amri H, Ben Abla T, M'rad MF.

Encephale. 2009 Sep;35(4):347-52. doi: 10.1016/j.encep.2008.04.006. Epub 2008 Sep 20. French.

PMID:
19748371
10.

Summer birth and deficit schizophrenia in Nithsdale, Scotland.

Tek C, Kirkpatrick B, Kelly C, McCreadie RG.

J Nerv Ment Dis. 2001 Sep;189(9):613-7.

PMID:
11580005
11.

Cost effectiveness of day and inpatient psychiatric treatment: results of a randomised controlled trial.

Creed F, Mbaya P, Lancashire S, Tomenson B, Williams B, Holme S.

BMJ. 1997 May 10;314(7091):1381-5.

12.

[Schizophrenia diagnostic announcement in a French psychiatric unit].

Rocamora JF, Benadhira R, Saba G, Stamatadis L, Kalalaou K, Dumortier G, Plaze M, Aubriot-Delmas B, Glikman J, Januel D.

Encephale. 2005 Jul-Aug;31(4 Pt 1):449-55. French.

PMID:
16389712
13.
14.

[Cannabis and schizophrenia: demographic and clinical correlates].

Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olié JP, Lôo H, Krebs MO.

Encephale. 2003 Jan-Feb;29(1):11-7. French.

PMID:
12640322
15.
16.
17.

[A critical study of the influence of negative symptoms on the therapeutic response in schizophrenia].

Acuña MJ, Martín J, Noval D, Blanco M.

Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1998 Jul-Aug;26(4):209-13. Spanish.

PMID:
9807853
18.
19.

Residential program for long-term hospitalized persons with mental illness in Japan: Randomized controlled trial.

Chan H, Inoue S, Shimodera S, Fujita H, Fukuzawa K, Kii M, Kamimura N, Kato K, Mino Y.

Psychiatry Clin Neurosci. 2007 Oct;61(5):515-21.

20.

Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.

Lewis SW, Davies L, Jones PB, Barnes TR, Murray RM, Kerwin R, Taylor D, Hayhurst KP, Markwick A, Lloyd H, Dunn G.

Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165.

Supplemental Content

Support Center